Clinical Trials Logo

Clinical Trial Summary

The ability to explain bleeding or clotting complications in patients treated with dabigatran remains challenging. In addition, there is limited data on how coagulation tests perform in patients treated with therapeutic doses of dabigatran. Predicted responses of coagulation tests to therapeutic doses of dabigatran may be helpful in better understanding abnormal responses to dabigatran. The purpose of the study is to define a therapeutic reference range for peak and trough coagulation tests in patients taking FDA approved doses of dabigatran and to determine which tests may be most clinically useful for monitoring dabigatran.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01588327
Study type Observational
Source University of North Carolina, Chapel Hill
Contact
Status Completed
Phase N/A
Start date October 2011
Completion date March 2012

See also
  Status Clinical Trial Phase
Recruiting NCT03647254 - Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study) N/A
Unknown status NCT02255214 - Evaluation of the Accuracy of the Hemochron Signature Elite Point of Care Device Compared With Laboratory Assay N/A
Completed NCT03280368 - Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation
Recruiting NCT01167660 - Non Invasive Measurement of Coagulation in Term and Preterm Neonates N/A
Terminated NCT02839434 - Evaluation of the Interference of Antithrombotic Agents With Laboratory Monitoring of Heparin Therapy